PMH4 2-YEAR OUTCOMES OF RISPERDAL® CONSTATM-THE FIRST ATYPICAL LONG ACTING INJECTABLE ANTIPSYCHOTIC: RESULTS FROM THE CANADIAN NATIONAL OUTCOMES MEASUREMENT STUDY IN SCHIZOPHRENIA

✍ Scribed by K Trakas; D Talling; R Balshaw; L Love; K Robinson

• Book ID: 119592683
• Publisher: John Wiley and Sons
• Year: 2003
• Tongue: English
• Weight: 65 KB
• Volume: 6
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)61762-7